What does CUSIP 74365N103 represent in this 13F holders report?

CUSIP 74365N103 is the security identifier for PTIX - PROTAGENIC THERAPEUTICS INC - COM used to aggregate holder disclosures.

How many institutions held PTIX - PROTAGENIC THERAPEUTICS INC - COM in Q1 2022?

12 institutional investors reported PTIX - PROTAGENIC THERAPEUTICS INC - COM for Q1 2022. Use the holders table for investor-level position and value details.

PROTAGENIC THERAPEUTICS INC - COM (PTIX)

CUSIP: 74365N103

Q1 2022 13F Holders as of 31 Mar 2022

Security type / class: Equity / COM
Total 13F shares: 673,973
Total 13F value: $548,000
Share change: -279,579
SEC-reported price per share: $0.81
Number of holders: 12
Value change: -$262,322
Number of buys: 5
Number of sells: 6

Security key

74365N103

Report period

Q1 2022

Institutions

Top holders

PTIX full security history Ownership snapshot Full 13F holder table Protagenic Therapeutics, Inc.\new SEC filings Protagenic Therapeutics, Inc.\new company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of PTIX - PROTAGENIC THERAPEUTICS INC - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

ORACLE INVESTMENT MANAGEM...

Disclosed value leader

ORACLE INVESTMENT MANAGEM...

Comparable rows

0/14

Latest evidence

31 Dec 2021

13F Highest disclosed value: $416,000 14 rows are not safely comparable across share classes. Showing 1-6 of 14 holder rows.

Quick read

ORACLE INVESTMENT MANAGEMENT INC has the largest disclosed position value at $416K.

0 of 14 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ORACLE INVESTMENT MANAGEMENT INC's linked filing trail.

Disclosed position value Top 5

ORACLE INVESTMENT MANAGEMENT INC $416K

VANGUARD GROUP INC $350K

GEODE CAPITAL MANAGEMENT, LLC $143K

FNY Investment Advisers, LLC $103K

RENAISSANCE TECHNOLOGIES LLC $84K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 14 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
ORACLE INVESTMENT MANAGEMENT INC	13F Company 13F	— denominator unverified	$416,000 300,267 shares	—	31 Dec 2021
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$350,000 252,825 shares	—	31 Dec 2021
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	— denominator unverified	$143,000 103,879 shares	—	31 Dec 2021
FNY Investment Advisers, LLC	13F Company 13F	— denominator unverified	$103,000 74,800 shares	—	31 Dec 2021
RENAISSANCE TECHNOLOGIES LLC	13F Company 13F	— denominator unverified	$84,000 60,400 shares	—	31 Dec 2021
STATE STREET CORP	13F Company 13F	— denominator unverified	$75,000 54,400 shares	—	31 Dec 2021

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

673,973

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2022 vs Q1 2022 Across Filers

Q1 2022 holders

Holder diff

Investor	Q1 2022 Shares	Q1 2022 Shares	Share Diff	Share Chg %	Q1 2022 value	Q1 2022 value	Value change	Value Chg %